Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements?
- PMID: 22297819
- PMCID: PMC3277217
- DOI: 10.1038/mt.2011.288
Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements?
References
-
- Hacein-Bey-Abina S, von Kalle KC, Schmidt M, Le Deist F, Wulffraat N, McIntyre E.et al. (2003A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency N Engl J Med 348255–256. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
